Wound Care Biologics Market Growth Analysis, Industry Outlook, Business Prospects and Forecast to 2025
MarketStudyReport.com offers 2019 report on global Wound Care Biologics market report that evaluates industry growth trends through historical data and estimates future prospects based on comprehensive research. The report extensively provides the market share, growth, trends and forecasts for the period 2019-2025.
Selbyville, Delaware – April 29, 2019 /MarketersMedia/ —
MarketStudyReport.com offers 2019 report on global Wound Care Biologics market that evaluates industry growth trends through historical data and estimates future prospects based on comprehensive research. The report extensively provides the market share, growth, trends and forecasts for the period 2019-2025.
Key industry players operational in wound care biologics market includes Smith & Nephew, Integra Life Sciences, M?lnlycke Health Care AB, Mimedx Group, Wright Medical, Osiris Therapeutics, Kerecis, Amnio Technology, Derma Sciences, Solsys Medica and Skye Biologics. Prominent industry players implement several organic as well as inorganic growth strategies for maintaining their market share. For instance, in January 2017, Integra Life Sciences acquired Derma Sciences. This acquisition will enable Integra Life Sciences to expand its product portfolio that will also help in increasing company’s revenue.
Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1534302
Venous leg ulcers segment was valued USD 195.0 million in 2018 and is expected to have enormous growth throughout the analysis period. Venous leg ulcers are often caused due to obstruction in the functioning of blood supply from legs to heart for purification. The veins in the leg can disrupt and stop blood supply causing weakening of skin due to increased pressure on the limbs. This reduces the rate of wound healing and makes a person more susceptible to leg ulcers on occurrence of any sort of minor injury. Skin substitutes are preferred in the treatment of venous leg ulcers that should propel segmental growth.
Venous leg ulcers segment was valued USD 195.0 million in 2018 and is expected to have enormous growth throughout the analysis period. Venous leg ulcers are often caused due to obstruction in the functioning of blood supply from legs to heart for purification. The veins in the leg can disrupt and stop blood supply causing weakening of skin due to increased pressure on the limbs. This reduces the rate of wound healing and makes a person more susceptible to leg ulcers on occurrence of any sort of minor injury. Skin substitutes are preferred in the treatment of venous leg ulcers that should propel segmental growth.
Wound Care Biologics Market will exceed USD 2.5 billion by 2025; as per a new research report. Rising government initiatives that helps in lowering the cost of wound care biologics will prove beneficial for industry growth. Recently developed wound care biologic products are relatively expensive and thus, would create affordability issues. Therefore, government in developing countries implements certain initiatives that will resolve the affordability issues and will subsequently increase their demand over the forthcoming years. Moreover, the government in developed countries is engaged in lowering the prices of wound healing products being utilized by ambulatory surgical centers and public hospitals that further stimulates the wound care biologics market growth.
Topical agent segment will witness 8.9% CAGR during the analysis period. Topical agents include ointments, creams, lotions. Recently developed topical agents are also known to stimulate the process of wound healing. Doctors and physicians have high preference for using topical agents as they possess similar level of efficacy as that of the oral formulations. Also, topical agents have fewer side effects that will increase its demand over other wound healing products accelerating the segmental growth.
Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1534302/
India wound care biologics market accounted for 19.5% revenue share of the Asia Pacific wound care biologics market in 2018 and is anticipated to witness exponential growth during forecast timeframe. Also, there are improvements in the Indian public healthcare system that ensures availability of superior quality wound healing products. Moreover, prevalence of chronic diseases such as diabetes and STDs such as AIDS is high amongst the Indian population that increases the demand for surgical procedures proving beneficial for industry growth. Additionally, public organizations take initiatives to ensure optimal availability of medical resources that includes variety of wound dressings augmenting the industry growth in foreseeable future.
Hospitals segment will grow at 8.8% till 2025 as a result of growing utilization of wound healing products such as topical agents and skin substitutes in hospitals. Growing cases of diabetic foot ulcers, venous leg ulcers, surgical wounds and burns will increase the demand for wound care biologic products utilized in healing the post-surgical wounds thus, positively influencing the segmental growth.
Table of content:
Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. Wound care biologics industry 360 degree synopsis, 2014 – 2025
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Wound type trends
2.1.4. End-use trends
2.1.5. Regional trends
Chapter 3. Wound Care Biologics Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2014 – 2025
3.3. Industry impact forces
3.4. Regulatory landscape
3.5. Growth potential analysis
3.6. Competitive landscape, 2018
3.7. Porter’s analysis
3.8. PESTEL analysis
Chapter 4. Wound Care Biologics Market, By Product
4.1. Key segment trends
4.2. Skin substitutes
4.3. Topical agents
Chapter 5. Wound Care Biologics Market, By Wound Type
5.1. Key segment trends
5.2. Diabetic foot ulcers
5.3. Venous leg ulcers
5.4. Pressure ulcers
5.5. Surgical wounds
5.6. Burns
5.7. Others
Chapter 6. Wound Care Biologics Market, By End-use
6.1. Key segment trends
6.2. Hospitals
6.2.1. Market size, by region, 2014-2025 (USD Million)
6.3. Ambulatory surgical centers
6.3.1. Market size, by region, 2014-2025 (USD Million)
6.4. Others
6.4.1. Market size, by region, 2014-2025 (USD Million)
Chapter 7. Wound Care Biologics Market, By Region
Chapter 8. Company Profiles
More Details on this Report At: https://www.marketstudyreport.com/reports/wound-care-biologics-market
Related Report:
lobal Wound Care Biologics Market Growth 2019-2024
In the last several years, Global market of Wound Care Biologics developed rapidly. North America region is the largest supplier of Wound Care Biologics, with a production value market share nearly 57.81%. Europe is the second largest supplier of Wound Care Biologics, enjoying production value market share nearly 29.10%.
About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog
Contact Info:
Name: Arun Hegde
Email: Send Email
Organization: Market Study Report
Address: 4 North Main Street, Selbyville, Delaware 19975 USA
Phone: 1-302-273-0910
Website: https://www.marketstudyreport.com
Source: MarketersMedia
Release ID: 507054
Copyright © 1999-2013 SproutNews.com
